Evidence map›Paper›PMID 36384335›Full record

ArticleThe neuroradiology journal2023

Two cases of flow void sign of temporal bone metastasis from follicular thyroid carcinoma.

Yukako Iritani, Hiroki Kato, Yo Kaneko, Hirofumi Shibata, Ryota Iinuma, Takenori Ogawa, Natsuko Suzui, Tatsuhiko Miyazaki, Masayuki Matsuo

Open access · greenAbstract readCase Reports
In one paragraph

Article in The neuroradiology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yukako IritaniDepartment of Radiology, Gifu University, Gifu, Japan.
Hiroki KatoDepartment of Radiology, Gifu University, Gifu, Japan.ORCID 0000-0001-5926-1895
Yo KanekoDepartment of Radiology, Gifu University, Gifu, Japan.
Hirofumi ShibataDepartment of Otolaryngology, Gifu University, Gifu, Japan.
Ryota IinumaDepartment of Otolaryngology, Gifu University, Gifu, Japan.
Takenori OgawaDepartment of Otolaryngology, Gifu University, Gifu, Japan.
Natsuko SuzuiDepartment of Pathology, Gifu University Hospital, Gifu, Japan.
Tatsuhiko MiyazakiDepartment of Pathology, Gifu University Hospital, Gifu, Japan.
Masayuki MatsuoDepartment of Radiology, Gifu University, Gifu, Japan.
Gifu University · JPGifu University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes CT and MRI findings of temporal bone metastasis from follicular thyroid carcinoma in two cases. Both of these had large, osteolytic, hypervascular masses of the temporal bone, accompanied by internal scattered bone fragments and extraosseous mass formation on unenhanced and contrast-enhanced CT images. In the first case, several dilated and tortuous vessels within the markedly hypervascular mass were observed on the arterial phase of dynamic contrast-enhanced CT images. Compared with the signal intensity of the cerebellum, temporal bone masses showed slightly hypo- to slightly hyperintense on T1-weighted images and slightly hypo- to moderately hyperintense on T2-weighted images. Both cases had flow voids in abnormally dilated vessels within the mass on T1- and T2-weighted images. Thyroid follicular carcinoma rarely metastasizes the temporal bone and presents with an osteolytic hypervascular mass with flow void sign.

Indexed as

Adenocarcinoma, FollicularThyroid NeoplasmsContrast MediaFemaleHumansMagnetic Resonance ImagingMiddle AgedRetrospective StudiesTemporal BoneContrast MediaCTflow voidFollicular thyroid carcinomaMRItemporal bone metastasis

Identifiers

PMID36384335
PMCPMC10268090
OpenAlexW4309245904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.